Business Context and Reporting Period
Company: Envoy Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 19, 2025
Reporting Period: Event date November 19, 2025; Compliance deadline May 18, 2026.
Business Overview: The Company is an emerging growth company incorporated in Delaware, with Class A Common Stock (COCH) and Redeemable Warrants (COCHW) listed on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory listing status rather than financial performance.
Material Changes
Nasdaq Non-Compliance Notice: On November 19, 2025, the Company received a staff determination notice from Nasdaq stating that its Class A Common Stock failed to comply with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).
Duration of Deficiency: The stock traded below the $1.00 threshold for the 30 consecutive business days prior to the notice date.
Immediate Effect: The notice has no immediate effect on the listing of the Common Stock.
Outlook, Management Commentary, and Risks
- Compliance Period: The Company has been granted an initial 180-calendar-day compliance period, ending on May 18, 2026.
- Regaining Compliance: To maintain listing, the closing bid price must meet or exceed $1.00 per share for a minimum of 10 consecutive business days prior to the Compliance Date.
- Secondary Compliance Option: If the Company fails to regain compliance by May 18, 2026, it may be eligible for an additional 180-day period. Qualification requires meeting the market value of publicly held shares and other initial listing standards (excluding bid price) and may necessitate a reverse stock split.
- Delisting Risk: Failure to qualify for or succeed in the second compliance period will result in a delisting determination, subject to appeal to a Hearings Panel.
- Management Action: The Company intends to monitor the closing bid price and will consider implementing available options, including a reverse stock split, to regain compliance.
Investor Verification Checklist
- Verify the current closing bid price of Envoy Medical, Inc. (COCH) relative to the $1.00 threshold.
- Monitor the Company's stock price performance over the next 10 consecutive business days leading up to May 18, 2026.
- Watch for announcements regarding a potential reverse stock split to address the bid price deficiency.
- Review the Company's market value of publicly held shares to assess eligibility for a second compliance period if the first is missed.
- Check for any subsequent 8-K filings regarding the status of the compliance period or delisting appeals.